UNSPSC 51392806: Imazodan hydrochloride

This classification denotes a phosphodiesterase inhibitor with the molecular formula C13H12N4O.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5EP74J9Q34, chemically known as 4,5-dihydro-6-(p-imidazol-1-ylphenyl)-3(2h)-pyridazinone monohydrochloride but more generally known as imazodan hydrochloride, which bears US NIH Compound Identifier 55917. Most nations, for tariff and trade purposes, schedule imazodan hydrochloride under HS 29332990 and SITC 51573.

As of Q4 2014, IMAZODAN HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Imazodan hydrochloride bears US NLM identifiers UMLS ID C0956497 and NCI Concept Code C72811. SMILES: C1CC(CCC1C2=NNC(=O)CC2)N3CCNC3.CL.

UNSPSC 51392806 Imazodan hydrochloride is a Commodity code that does not align with the recent state and local procurement activity tagged under it. The one recent opportunity on record—Seminole County, Florida's IFB60459723LAS, posted June 30, 2026—solicits naloxone and safe drug deactivation systems, not imazodan hydrochloride. The county is seeking 1,900 units of naloxone and 800 drug deactivation systems annually through competitive bidding to support community health initiatives, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. Vendors must submit electronic bids through the county's e-Procurement Portal and include all shipping and delivery costs; the contract carries a two-year initial term with a one-year renewal option. This code shows little relevant recent activity in state and local procurement for imazodan hydrochloride specifically.

The geographic and issuing-body footprint is minimal. Only Seminole County, Florida appears in the recent-opportunities record. The single solicitation reflects county-level health procurement rather than broader state, municipal, or school-district activity under this code. Without additional opportunities in the dataset, no meaningful characterization of geographic concentration or issuing-body diversity is supported. Prospective vendors should verify whether this code designation reflects actual imazodan hydrochloride procurement elsewhere in their target states before committing resources to market development under this taxonomy entry.